Genome Atlantic joins Dalhousie University and BioNova in welcoming Dr. Marlene Haffner for a discussion on Thursday, Jan.20th about the regulatory aspects of drug development, highlighting changes and challenges with the USFDA, with a particular emphasis on orphan diseases.

Dr. Haffner has received many awards for her work in drug development including The Outstanding Contributions to Pharmaceutical Medicine Award from the Academy of Pharmaceutical Physicians, and in May 2009, The Woodrow Wilson Award for Outstanding Government Service from the John Hopkins University.

Highlights of Dr. Haffner’s career include:
• CEO, Haffner Associates, LLC
• Executive Director, Global Regulatory Policy and Intelligence at Amgen
• Director of Orphan Products Development, FDA
• Adjunct Professor, Department of Preventative Medicine and Biometrics, F. Edward Hébert School of Medicine
• Clinical Professor, Department of Medicine, F. Edward Hébert School of Medicine

I'm a Disease - Where's My Drug? with Dr. Marlene Haffner

January 20, 2011
12:00 - 1:00 PM
Room 44
Bethune Building
5820 University Ave.

A light lunch will be served at 11:45 AM

Please RSVP before noon on January 17, 2011 to Ciara McGlinchey at:
info@bionova.ca or
421-5705